Heron Therapeutics, Inc. (HRTX) Social Stream
Heron Therapeutics Inc (HRTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Heron Therapeutics Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 3 | $60 | $23 | $33 | $5.54 | 495.67% |
| 2022-03-01 | 4 | $60 | $23 | $33 | $5.54 | 495.67% |
| 2022-03-02 | 4 | $60 | $13 | $27.2 | $5.54 | 390.97% |
The Trend in the Analyst Price Target
Over the past 14 months, HRTX's average price target has gone down $4.9.
Over the past 48 weeks, HRTX's average upside potential has been 184.86%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-10 | 3 | 70 | 25 | 34.00 | 16.60 | 104.82% |
| 2021-06-26 | 3 | 70 | 22 | 32.89 | 16.62 | 97.89% |
| 2021-07-10 | 8 | 70 | 25 | 34.25 | 14.02 | 144.29% |
| 2021-09-11 | 7 | 60 | 23 | 33.00 | 11.65 | 183.26% |
| 2021-12-10 | 3 | 60 | 23 | 33.00 | 9.02 | 265.85% |
HRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 22 months, HRTX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HRTX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Heron Therapeutics Inc's variance in analysts' estimates is lower than -284.9% of them.
- In terms of how Heron Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 383% of that group.
- In the context of stocks in the mid market cap category, Heron Therapeutics Inc's number of analysts covering the stock is greater than 55.37% of them.
- In the context of stocks in the mid market cap category, Heron Therapeutics Inc's average analyst price target is greater than 144.73% of them.
Stocks similar to Heron Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HRMY, HCM, and GBT.
Is HRTX a Buy, Hold or Sell? See the POWR Ratings now!